SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-09-026737
Filing Date
2009-02-12
Accepted
2009-02-12 12:23:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 2 dsc13ga.htm SC 13G/A 60127
  Complete submission text file 0001193125-09-026737.txt   62087
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 09593149
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 152 WEST 57TH ST 24TH FLOOR NEW YORK NY 10019 2126989260
FGS ADVISORS LLC (Filed by) CIK: 0001266114 (see all company filings)

IRS No.: 134043004 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A